Utility of hyposmia and hypogeusia for the diagnosis of COVID-19

Lancet Infect Dis. 2020 Sep;20(9):1014-1015. doi: 10.1016/S1473-3099(20)30297-8. Epub 2020 Apr 15.

Authors

François Bénézit¹, Paul Le Turnier², Charles Declerck³, Cécile Paillé², Matthieu Revest¹, Vincent Dubée³, Pierre Tattevin⁴; RAN COVID Study Group

Affiliations

¹ Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France.
² Infectious Diseases and Tropical Medicine, Hotel Dieu, University Hospital of Nantes, France.
³ Infectious Diseases and Tropical Medicine, University Hospital of Angers, France.
⁴ Infectious Diseases and Intensive Care Unit, Pontchaillou University Hospital, Rennes, France. Electronic address: [email protected].

No abstract available

Publication types

Letter

MeSH terms

Ageusia / complications*
Ageusia / physiopathology
Betacoronavirus / genetics
Betacoronavirus / isolation & purification*
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / diagnosis*
Coronavirus Infections / physiopathology
Coronavirus Infections / virology
France
Humans
Internet
Olfaction Disorders / complications*
Olfaction Disorders / physiopathology
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / diagnosis*
Pneumonia, Viral / physiopathology
Pneumonia, Viral / virology
Retrospective Studies
SARS-CoV-2
Surveys and Questionnaires